MYR Group Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
THORNTON, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading […]
Udemy Announces Share Repurchase Program
SAN FRANCISCO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading online skills marketplace and learning platform, today […]
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting
MENLO PARK, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an […]
1stDibs Appoints Everette Taylor to Its Board of Directors
NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — 1stdibs.com, Inc. (NASDAQ: DIBS), a leading online marketplace for luxury design products, […]
Sovos Brands Announces Fourth Quarter and Fiscal Year 2023 Earnings Date
LOUISVILLE, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) — Sovos Brands, Inc. (“Sovos Brands” or the “Company”) (Nasdaq: SOVO) will announce […]
Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
IRVINE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]
Fidus Investment Corporation Declares First Quarter 2024 Dividend
EVANSTON, Ill., Feb. 14, 2024 (GLOBE NEWSWIRE) — Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that its […]
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
ALISO VIEJO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated […]
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
SAN DIEGO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter […]
Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease
-Highlights potential uses of Celularity biomaterials in regenerative medicine applications that combine stem cells and biomaterial scaffolds for use in […]
